These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19695689)

  • 1. Comparative effectiveness research: a proposal for funding in ovarian cancer.
    Markman M
    Gynecol Oncol; 2009 Nov; 115(2):182-3. PubMed ID: 19695689
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness research in oncology: the need for clarity, transparency and vision.
    Lyman GH
    Cancer Invest; 2009 Jul; 27(6):593-7. PubMed ID: 19557579
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative effectiveness research.
    Pentecost MJ
    J Am Coll Radiol; 2009 Aug; 6(8):547-8. PubMed ID: 19643380
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate about funding comparative-effectiveness research.
    Avorn J
    N Engl J Med; 2009 May; 360(19):1927-9. PubMed ID: 19420361
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient-reported outcomes: clinical trials in ovarian cancer.
    Carey MS; Gotay C;
    Int J Gynecol Cancer; 2011 May; 21(4):782-7. PubMed ID: 21543941
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effectiveness research: we must lead (so as not to be misled).
    Lubowitz JH; Poehling GG
    Arthroscopy; 2009 May; 25(5):455-6. PubMed ID: 19409301
    [No Abstract]   [Full Text] [Related]  

  • 7. Questioning technology. Calif. Blues' foundation grant spearheads research.
    Benko LB
    Mod Healthc; 2006 Sep; 36(37):10, 12. PubMed ID: 17037828
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effectiveness research.
    Demaria AN
    J Am Coll Cardiol; 2009 Mar; 53(11):973-5. PubMed ID: 19281929
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing management of recurrent epithelial ovarian cancer: a critical need for evidence-based data.
    Markman M
    Oncology; 2006; 71(5-6):309-11. PubMed ID: 17873498
    [No Abstract]   [Full Text] [Related]  

  • 10. What does cost have to do with it?
    Cohn DE
    Gynecol Oncol; 2011 Sep; 122(3):465-6. PubMed ID: 21821169
    [No Abstract]   [Full Text] [Related]  

  • 11. The decision to conduct a head-to-head comparative trial: a game-theoretic analysis.
    Mansley EC; Elbasha EH; Teutsch SM; Berger ML
    Med Decis Making; 2007; 27(4):364-79. PubMed ID: 17761957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost, quality of life and outcome measures in ovarian cancer.
    Abbas FM; Sert MB
    Anticancer Drugs; 1998 Nov; 9(10):859-67. PubMed ID: 9890697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an internal research funding program in a school of veterinary medicine.
    Baker DG; Kearney MT
    J Vet Med Educ; 2012; 39(1):39-45. PubMed ID: 22433740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the public health research agenda for ovarian cancer.
    Trivers KF; Stewart SL; Peipins L; Rim SH; White MC
    J Womens Health (Larchmt); 2009 Sep; 18(9):1299-305. PubMed ID: 19702475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the lean days for research funding finally coming to an end?
    Gray C
    CMAJ; 1997 Jun; 156(12):1748-9. PubMed ID: 9220931
    [No Abstract]   [Full Text] [Related]  

  • 16. [Financing of health research. Fewer telegenic diseases and fewer wellknown funds].
    Spanjer JM
    Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1787-9. PubMed ID: 8371826
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroblastoma, well-designed evaluations, and the optimality of research funding: ask not what your country can do for you ..
    Levy IG
    J Natl Cancer Inst; 2005 Aug; 97(15):1105-6. PubMed ID: 16077062
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness studies: are they always cost effective?
    Kozma CM
    Manag Care Interface; 1999 Nov; 12(11):64-5. PubMed ID: 11184272
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medical-economic analysis of the treatment of advanced ovarian cancer].
    Dvorák O; Federmann J; Honzáková L
    Cesk Gynekol; 1982 Dec; 47(10):755-63. PubMed ID: 7159949
    [No Abstract]   [Full Text] [Related]  

  • 20. In search of evidence: is there the will and a way?
    Benson AB
    Arch Intern Med; 2005 Oct; 165(19):2194-5. PubMed ID: 16246979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.